Delivery Order SPE2DB22D3102-SPE2DB24FL1XF

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,388,147 units of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The $7,139.64 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on April 24, 2024, with a completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The $1,437.02 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: KABZK8W6PQT3) is a $3,637.01 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award has a period of performance through November 6, 2023 and is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,295.07 firm fixed-price contract is for the delivery of the pharmaceutical product Xulane 150-35 MCG/Day Patch 3S. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
The federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,676.94, is a Delivery Order from the Defense Logistics Agency (DLA) for the supply of the contraceptive patch XULANE 150-35 MCG/DAY PATCH 3S. This contract is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The $4,781.64 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics and acquisition support to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,673.24 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" to the Defense Logistics Agency (DLA), a defense agency. The $1,192.24 firm fixed-price delivery order contract has a completion date of May 7, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,657.29, for the supply of XULANE 150-35 MCG/DAY PATCH pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The $1,110.45 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL1XF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The $3,800.16 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.

Amerisourcebergen holds a significant single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, the company provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/2/24, 10:40 AM